Skip to main content

3 Result(s)

within Oncology Remove this filter B Szabados Remove this filter

and

  1. No Access

    Article

    Cytoreductive nephrectomy in metastatic renal cell carcinoma: outcome of patients treated with a multidisciplinary, algorithm-driven approach

    Metastatic renal cell carcinoma (mRCC) represents a significant and rising burden of disease, with rapidly evolving treatment modalities. The role of cytoreductive nephrectomy (CN) is controversial in this set...

    Wing K. Liu, J. M. Lam, T. Butters, M. Grant, F. Jackson-Spence… in World Journal of Urology (2020)

  2. No Access

    Article

    Adjuvant therapy in renal cell carcinoma: the perspective of urologists

    Until recently, there was no approved adjuvant therapy (AT) for renal cell carcinoma (RCC) unless sunitinib was approved in the US. We evaluated clinical opinion and estimated use regarding different treatment...

    Annabel Spek, B. Szabados, J. Casuscelli… in International Journal of Clinical Oncology (2019)

  3. No Access

    Article

    Nachsorge beim Nierenzellkarzinom im nicht fernmetastasierten Stadium

    Die postoperative Nachsorge nach kurativer operativer oder ablativer Therapie gehört zum Standard bei der Behandlung von Patienten mit nichtmetastasiertem Nierenzellkarzinom. Die Nachsorge dient der frühzeitig...

    B. Szabados, S. Foller, G. B. Schulz, M. Staehler, M.-O. Grimm, C. G. Stief… in Der Onkologe (2019)